Clinical Trial Update: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating antirotiinib hydrochloride in combination with whole brain radiotherapy for small cell lung cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Small Cell Lung Cancer

Drugs mentioned

• Antirotinib Hydrochloride (antirotinib hydrochloride)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Whole Brain Radiotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING